Fresenius Medical Care (FMS) net assets (shareholders' equity)
Fresenius Medical Care (FMS) had net assets of €13.31B at the end of fiscal 2025 (December 31, 2025). That is 8.7% lower than the €14.58B of fiscal 2024. Figures as of 18 Nov 2026, 23:46 UTC, from Yahoo Finance.
Key facts
- Net assets, fiscal 2025
- €13.31B
- Change on fiscal 2024
- −8.7%
- Highest on record
- €14.58Bfiscal 2024
- Lowest on record
- €13.31Bfiscal 2025
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.
Fresenius Medical Care net assets (shareholders' equity), in more detail
Across the 4 fiscal years on record (2022–2025), the highest was €14.58B in fiscal 2024 and the lowest €13.31B in fiscal 2025.
Net assets by fiscal year
Fresenius Medical Care net assets (shareholders' equity), year by year
| Fiscal year | Net assets | Change | Year ended |
|---|---|---|---|
| 2025 | €13.31B | 8.7% down | |
| 2024 | €14.58B | 7.0% up | |
| 2023 | €13.62B | 2.6% down | |
| 2022 | €13.99B | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.
How to read it
Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.
Net assets at health care companies of similar size
| Company | Net assets | Fiscal year |
|---|---|---|
| Cooper Companies COO | $8.24B | 2025 |
| Fresenius Medical Care FMS | €13.31B | 2025 |
| Kymera Therapeutics KYMR | $1.58B | 2025 |
| DaVita DVA | -$651.08M | 2025 |
| Halozyme Therapeutics HALO | $48.81M | 2025 |
| Universal Health Services UHS | $7.28B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Fresenius Medical Care, figure by figure
- Fresenius Medical Care market cap
- Fresenius Medical Care revenue
- Fresenius Medical Care earnings
- Fresenius Medical Care earnings per share (EPS)
- Fresenius Medical Care P/E ratio
- Fresenius Medical Care P/S ratio
- Fresenius Medical Care P/B ratio
- Fresenius Medical Care free cash flow
- Fresenius Medical Care operating margin
- Fresenius Medical Care dividend
- Fresenius Medical Care shares outstanding
- Fresenius Medical Care total debt
- Fresenius Medical Care cash on hand
- Fresenius Medical Care total assets
- Fresenius Medical Care total liabilities
- Fresenius Medical Care return on equity (ROE)
- Fresenius Medical Care return on invested capital (ROIC)
Fresenius Medical Care (FMS) overview: price, valuation and scorecardAll health care companies by market value
Fresenius Medical Care net assets (shareholders' equity): questions and answers
What are Fresenius Medical Care's net assets?
Fresenius Medical Care (FMS) had net assets of €13.31B at the end of fiscal 2025 (December 31, 2025). That is 8.7% lower than the €14.58B of fiscal 2024.
What are the highest and lowest net assets figures on record for Fresenius Medical Care?
Across the 4 fiscal years on record (2022–2025), the highest was €14.58B in fiscal 2024 and the lowest €13.31B in fiscal 2025.
How is Fresenius Medical Care's net assets calculated?
Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Fresenius Medical Care it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: net assets (shareholders' equity)
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Fresenius Medical Care (FMS) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/FMS/net-assets
Underlying data: Yahoo Finance.